A5037254746- Health Systems, Economic Evaluations, Quality of Life
- Pharmaceutical Economics and Policy
- Biomedical Ethics and Regulation
- Patient-Provider Communication in Healthcare
- Economic and Financial Impacts of Cancer
- Ethics in Clinical Research
- Social Media in Health Education
- CAR-T cell therapy research
- Statistical Methods and Inference
- Pharmaceutical industry and healthcare
- Mental Health and Patient Involvement
- Meta-analysis and systematic reviews
- Biosimilars and Bioanalytical Methods
- Statistical Methods and Bayesian Inference
- Innovative Microfluidic and Catalytic Techniques Innovation
- Scientific Computing and Data Management
- Cancer Immunotherapy and Biomarkers
- Biomedical and Engineering Education
- Advanced Causal Inference Techniques
- Pharmaceutical Quality and Counterfeiting
Newcastle University
2022-2025
National Institute for Health Research
2022-2025
Advanced therapy medicinal products (ATMPs) are innovative biological categorised as either gene, somatic cell, tissue-engineered or combined therapies. As of March 2022, 12 ATMPs marketed in the EU and UK. We identified 482 unique within 616 technology records from National Institute for Health Care Research Innovation Observatory database, 4 which currently marketed. These were 583 clinical trials. Of records, 57.1% gene therapies 1.6% Records covered various indications, including 130...
ABSTRACT Horizon scanning (HS) is a method for the identification of emerging change through systematic analysis trusted sources using defined scope and prespecified methods. In health research, it can provide early awareness potential developments ahead market access. Within medicines space, HS supported by international requirements clinical trial registration, conduct reporting, transparent regulatory processes. Potential changes be identified at different stages development, emerging,...
ABSTRACT Medicine repurposing is a strategy to identify new uses for the existing medicines purpose of addressing areas unmet medical need. This paper aims provide horizon scanning intelligence on repurposed that are evaluated by non‐commercial organizations such as academia and highlights opportunities further research improve patient health outcomes. A scan clinical landscape non‐commercially sponsored routinely conducted NIHR Innovation Observatory (IO). ongoing project involves trial...
ScanMedicine is a novel searching system dedicated to providing health care professionals, patients, carers, the public, decision- and policy-makers, researchers with open access development pipeline underpinning technology innovations. In first phase of developing ScanMedicine, we have focused on capturing consolidating clinical trial records hosted national international trials registries medical device approval data from FDA. has been developed based microservice architecture allowing be...
Medicine repurposing is a strategy to identify new uses for existing medicines the purpose of addressing areas unmet medical need. This paper aims provide horizon scanning intelligence on repurposed that are evaluated by non-commercial organisations such as academia, and highlights opportunities further research improve patient health outcomes. A scan clinical landscape non-commercially sponsored routinely conducted NIHR Innovation Observatory (IO). ongoing project involves trial registries...
Horizon scanning (HS) is a method for identification of emerging change through systematic analysis trusted sources using defined scope and prespecified methods. In health research it can provide early awareness potential developments ahead market access. Within the medicines space, HS supported by international requirements clinical trial registration, conduct reporting, transparent regulatory processes. Potential changes be identified at different stages development, emerging,...